Intellistake (CSE: ISTK / OTCQB: ISTKF) steps into decentralized AI with a C$500K FET allocation, joining the ASI Alliance and helping build the future of autonomous intelligence.

Artificial Intelligence is driving unprecedented datacentre demand, and energy providers are racing to supply sustainable, scalable power.

AI is reshaping drug discovery, cutting costs and accelerating development. Beyond billion-dollar leaders, micro-cap Rakovina Therapeutics offers early-stage exposure to this trend.

General AI models are impressive—but in high-stakes industries, they’re getting beat by smaller, specialized ones. This startup is building narrow AIs that know exactly what they’re talking about.